Coagulation & Hemostasis Testing Market - Global Forecast 2026-2032

The Coagulation & Hemostasis Testing Market is projected to reach USD 7.28 Billion in 2026. It is expected to continue growing at a CAGR of 11.61%, reaching USD 14.17 Billion by 2032.

Coagulation and hemostasis testing is a foundational area of clinical diagnostics, supporting the detection, monitoring, and management of bleeding disorders, thrombotic risk, liver disease, sepsis-related coagulopathy, perioperative bleeding, pregnancy complications, and anticoagulant therapy. Core assays such as prothrombin time and international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), D-dimer, fibrinogen, anti-Xa, platelet function testing, and viscoelastic testing are increasingly embedded across emergency medicine, cardiovascular care, oncology, trauma, intensive care, obstetrics, and surgical pathways.

Demand is supported by measurable public health drivers. The World Health Organization identifies cardiovascular diseases as the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. Venous thromboembolism, atrial fibrillation, cancer-associated thrombosis, inherited bleeding disorders, and broader anticoagulant use continue to elevate the importance of accurate, rapid, and standardized hemostasis diagnostics. As health systems prioritize earlier risk stratification, patient blood management, and outcome-based care, coagulation testing is moving from a narrow laboratory function to an essential decision-support capability across the patient journey.

Transformative Shifts in the Testing Landscape

The coagulation and hemostasis testing landscape is being reshaped by the transition from centralized, volume-driven testing toward faster, clinically integrated diagnostics. High-throughput automated analyzers remain critical in hospital and reference laboratories, but point-of-care coagulation testing is gaining traction in operating rooms, emergency departments, anticoagulation clinics, cardiac catheterization laboratories, and critical care units where time-sensitive decisions can affect transfusion use, anticoagulant reversal, thrombosis prevention, and surgical outcomes.

Clinical practice is also shifting as direct oral anticoagulants, anti-Xa monitoring, viscoelastic testing, D-dimer algorithms, and patient-specific bleeding and clotting risk models influence test menus. Laboratories are increasingly expected to deliver not only accurate results but also interpretive value, connectivity with laboratory information systems, quality control traceability, and compliance with evolving accreditation standards. These shifts are creating opportunities for manufacturers and service providers that can combine assay reliability, workflow efficiency, digital integration, and clinician-friendly reporting.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding a cumulative layer of value across coagulation and hemostasis testing by improving workflow prediction, quality management, and clinical interpretation. In laboratory operations, AI-enabled analytics can help identify analyzer drift, reagent lot variability, pre-analytical errors, abnormal result patterns, turnaround-time bottlenecks, and reflex testing opportunities. In clinical environments, machine learning models are being studied for venous thromboembolism prediction, bleeding risk stratification, sepsis-associated coagulopathy detection, perioperative risk assessment, and anticoagulation management.

The impact is strongest where AI is implemented as an evidence-based decision-support tool rather than as a replacement for laboratory expertise. U.S. regulatory authorization activity for AI-enabled medical devices has expanded rapidly across healthcare, signaling growing acceptance when performance, validation, bias assessment, and risk controls are demonstrated. For hemostasis testing, the practical advantage lies in combining structured coagulation results with electronic health record data, medication history, comorbidities, imaging, procedure data, and real-time clinical context to support faster, safer, and more consistent decisions.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East & Africa

Asia-Pacific is one of the most dynamic regions for coagulation and hemostasis testing, supported by expanding hospital infrastructure, rising cardiovascular disease burden, larger surgical volumes, and wider adoption of automated diagnostics in China, India, Japan, South Korea, and Australia. Japan and South Korea show strong uptake of advanced laboratory automation and digital hospital workflows, while China and India are expanding access across tertiary hospitals, urban diagnostic networks, and specialty care centers as noncommunicable disease management becomes a higher healthcare priority.

North America remains a high-value regional environment due to advanced hospital laboratories, broad anticoagulation management programs, trauma care networks, and strong adoption of specialty assays and point-of-care coagulation testing. The United States is a leading center for innovation in coagulation analyzers, reagents, informatics, clinical research, and regulatory science, while Canada benefits from organized public healthcare delivery and centralized laboratory systems. Europe benefits from mature laboratory quality systems, national healthcare coverage, and demand for standardized testing across the European Union, the United Kingdom, Germany, France, Italy, and Spain, with the In Vitro Diagnostic Regulation strengthening expectations for clinical evidence, performance evaluation, and post-market surveillance.

Latin America is advancing through private diagnostic networks, cardiovascular care expansion, and hospital modernization in Brazil and Mexico, although access gaps persist across rural and public-sector systems. The Middle East is investing in tertiary care, transplant programs, trauma centers, cardiovascular services, and specialty diagnostics, particularly in GCC countries with high healthcare infrastructure spending. Africa presents long-term potential as laboratory capacity improves, with current demand concentrated in urban hospitals and donor-supported healthcare systems addressing maternal health, surgery, infectious disease, transfusion safety, and emergency care.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

ASEAN markets are gaining momentum as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore strengthen hospital laboratory capacity and expand access to chronic disease management. Demand is rising for reliable PT/INR, D-dimer, fibrinogen, and perioperative coagulation testing, with Singapore serving as a regional hub for advanced diagnostics, laboratory accreditation practices, and clinical quality benchmarks.

The GCC is characterized by strong healthcare investment, high hospital spending, and the development of specialized centers for cardiovascular disease, oncology, trauma, transplant medicine, and complex surgery, all of which increase the need for sophisticated hemostasis testing. The European Union continues to emphasize diagnostic standardization, CE-marked technologies under the In Vitro Diagnostic Regulation framework, and cross-border quality expectations that influence procurement, validation, clinical evidence, and post-market performance practices.

BRICS economies represent a major volume environment because they combine large populations, rising noncommunicable disease burdens, expanding tertiary hospitals, and growing diagnostic networks. G7 countries lead in high-value adoption of automation, specialty assays, viscoelastic testing, point-of-care systems, and data-enabled laboratory platforms. NATO countries, with overlapping membership across North America and Europe, sustain demand through advanced emergency medicine, military trauma care, blood management programs, civil preparedness, and resilient healthcare infrastructure planning.

Key Country Insights Across Major Coagulation Testing Markets

The United States leads in clinical adoption, reimbursement maturity, and innovation for coagulation and hemostasis testing, supported by large hospital networks, reference laboratories, anticoagulation services, and FDA-regulated diagnostic pathways. Canada shows steady demand through publicly funded healthcare systems, centralized laboratory models, and quality-focused diagnostic services, while Mexico is advancing through private hospitals, diagnostic chains, and cardiovascular care expansion. Brazil is the largest Latin American opportunity, driven by tertiary hospital investment, public and private diagnostic demand, and increasing focus on cardiovascular and surgical care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand for routine and specialty hemostasis testing through established hospital laboratories, national healthcare systems, and guideline-driven clinical pathways. Germany is especially influential in laboratory automation, quality-driven procurement, and advanced clinical laboratory infrastructure, while France, Italy, and Spain support demand through cardiovascular, oncology, obstetric, and surgical care. Russia retains substantial testing needs across large hospital systems, although procurement dynamics may be affected by economic conditions, regulatory constraints, and trade limitations.

China and India are major growth engines due to population scale, rising cardiovascular and diabetes burden, hospital expansion, increasing surgical volumes, and broader use of automated analyzers in tertiary and urban diagnostic settings. Japan emphasizes high-quality diagnostics, aging-population care, anticoagulation management, and advanced laboratory systems. Australia has a sophisticated diagnostic environment with strong quality standards and established pathology networks, while South Korea combines advanced hospital infrastructure, digital health readiness, and strong adoption of automated clinical laboratory technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated testing portfolios that cover routine coagulation, D-dimer, fibrinogen, anti-Xa, specialty factor assays, platelet function, and viscoelastic testing. Competitive advantage will increasingly depend on reagent stability, analyzer uptime, sample throughput, traceable calibration, quality control performance, cybersecurity readiness, and seamless connectivity with laboratory information systems and electronic health records.

Organizations should invest in point-of-care platforms for emergency, perioperative, trauma, obstetric, cardiac, and anticoagulation settings while maintaining strong central laboratory automation. Partnerships with hospitals, reference laboratories, professional societies, and academic centers can support evidence generation, guideline alignment, workflow validation, and real-world clinical adoption. Leaders should also develop AI-enabled analytics under robust governance, with transparent validation, data privacy controls, bias monitoring, cybersecurity safeguards, and clinician-readable outputs that strengthen trust and adoption.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with market intelligence best practices. The analysis synthesizes publicly available evidence from health agencies, clinical guidelines, regulatory databases, peer-reviewed literature, hospital laboratory standards, accreditation frameworks, and diagnostic industry disclosures. Key reference areas include cardiovascular disease burden, anticoagulation trends, bleeding disorder management, venous thromboembolism risk, laboratory automation, point-of-care testing, in vitro diagnostic regulation, and AI-enabled healthcare technologies.

The methodology emphasizes triangulation across epidemiological indicators, healthcare infrastructure trends, regulatory developments, clinical adoption patterns, reimbursement environments, laboratory workflow requirements, and regional procurement dynamics. No unsupported market size, market share, or growth-rate claims are used. Insights are framed to support executive decision-making across product strategy, geographic prioritization, competitive positioning, quality management, access planning, and innovation strategy in coagulation and hemostasis testing.

Conclusion

Coagulation and hemostasis testing is evolving from a routine diagnostic category into a high-impact clinical decision-support ecosystem. The convergence of chronic disease burden, anticoagulant use, surgical complexity, trauma care, obstetric risk management, sepsis management, transfusion stewardship, and laboratory automation is expanding the role of accurate and timely hemostasis assessment across healthcare systems.

Future leadership will depend on platforms that deliver reliable assays, faster turnaround times, interoperable data, strong quality controls, and evidence-based AI support. Organizations that align innovation with clinical workflow, regulatory expectations, laboratory performance standards, and regional access needs will be best positioned to create long-term value in the global coagulation and hemostasis testing landscape.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Coagulation & Hemostasis Testing Market, by Product Type

7.1. Introduction
7.2. Instruments
7.2.1. Coagulation Analyzers
7.2.2. Point-of-Care Coagulometers
7.3. Reagents & Consumables
7.4. Software & Services
7.4.1. IVD Informatics Solutions
7.4.2. Maintenance & Support

8. Coagulation & Hemostasis Testing Market, by Technology

8.1. Introduction
8.2. Electrochemical Detection
8.3. Immunoassays
8.3.1. ELISA
8.3.2. Immunoturbidimetric
8.4. Microfluidics
8.5. Optical Detection

9. Coagulation & Hemostasis Testing Market, by Workflow

9.1. Introduction
9.2. Laboratory Based
9.3. Point Of Care

10. Coagulation & Hemostasis Testing Market, by Test Type

10.1. Introduction
10.2. aPTT Tests
10.3. D-Dimer Tests
10.4. Fibrinogen Tests
10.5. PT/INR Tests

11. Coagulation & Hemostasis Testing Market, by Automation Level

11.1. Introduction
11.2. Manual
11.3. Semi Automated
11.4. Fully Automated

12. Coagulation & Hemostasis Testing Market, by Application

12.1. Introduction
12.2. Bleeding Disorder Evaluation
12.3. Thrombotic Disorder Evaluation
12.4. Anticoagulant Therapy Monitoring
12.5. Perioperative Hemostasis Management
12.6. Trauma And Massive Transfusion Management
12.7. Liver Disease Assessment

13. Coagulation & Hemostasis Testing Market, by End User

13.1. Introduction
13.2. Diagnostic Labs
13.3. Hospital Labs
13.4. Physician Offices
13.5. Research Institutes

14. Coagulation & Hemostasis Testing Market, by Region

14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa

15. Coagulation & Hemostasis Testing Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Coagulation & Hemostasis Testing Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. Competitive Landscape

17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025

18. Company Profiles

18.1. Abbott Laboratories
18.2. AELAB Guangzhou Co., Ltd.
18.3. Autobio Diagnostics Co., Ltd.
18.4. Beijing Succeeder Technology Inc.
18.5. Bio-Rad Laboratories, Inc.
18.6. Bio/Data Corporation
18.7. Cardinal Health
18.8. Danaher Corporation
18.9. Diagnostica Stago SAS
18.10. F. Hoffmann-La Roche Ltd.
18.11. Haemonetics Corporation
18.12. Helena Laboratories Corporation
18.13. HemoSonics LLC
18.14. HORIBA, Ltd.
18.15. IDEXX Laboratories, Inc.
18.16. Machaon Diagnostics, Inc.
18.17. Medsource Ozone Biomedicals Pvt. Ltd.
18.18. Mindray Medical International Limited
18.19. QuidelOrtho Corporation
18.20. Raj Biosis Private Limited
18.21. Randox Laboratories Ltd
18.22. Sekisui Medical Co., Ltd.
18.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.24. Siemens Healthineers AG
18.25. Sterile Safequip USA LLC
18.26. Sysmex Corporation
18.27. Thermo Fisher Scientific Inc.
18.28. Universal Biosensors Pty Ltd.
18.29. Werfen S.A.

List of Figures

FIGURE 1. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE COAGULOMETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE COAGULOMETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE COAGULOMETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL IVD INFORMATICS SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL IVD INFORMATICS SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL IVD INFORMATICS SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ELECTROCHEMICAL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ELECTROCHEMICAL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ELECTROCHEMICAL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOTURBIDIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOTURBIDIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNOTURBIDIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL OPTICAL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL OPTICAL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL OPTICAL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL LABORATORY BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LABORATORY BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LABORATORY BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL APTT TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL APTT TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL APTT TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL D-DIMER TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL D-DIMER TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL D-DIMER TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FIBRINOGEN TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FIBRINOGEN TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FIBRINOGEN TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PT/INR TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PT/INR TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PT/INR TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MANUAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SEMI AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SEMI AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SEMI AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BLEEDING DISORDER EVALUATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BLEEDING DISORDER EVALUATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BLEEDING DISORDER EVALUATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL THROMBOTIC DISORDER EVALUATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL THROMBOTIC DISORDER EVALUATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL THROMBOTIC DISORDER EVALUATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ANTICOAGULANT THERAPY MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ANTICOAGULANT THERAPY MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ANTICOAGULANT THERAPY MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PERIOPERATIVE HEMOSTASIS MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PERIOPERATIVE HEMOSTASIS MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PERIOPERATIVE HEMOSTASIS MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TRAUMA AND MASSIVE TRANSFUSION MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TRAUMA AND MASSIVE TRANSFUSION MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TRAUMA AND MASSIVE TRANSFUSION MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL LIVER DISEASE ASSESSMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL LIVER DISEASE ASSESSMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL LIVER DISEASE ASSESSMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOSPITAL LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITAL LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITAL LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 142. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 144. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 145. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 146. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 147. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 148. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 149. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. EUROPE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 165. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 166. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 168. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 169. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 170. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 171. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 177. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 178. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 180. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 181. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 182. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 183. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. ASEAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 188. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 189. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 191. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 192. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 193. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 194. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. GCC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 210. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 211. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 213. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 214. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 215. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 216. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. BRICS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 221. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 222. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 223. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 224. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 225. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 226. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 227. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. G7 COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 232. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 233. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 235. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 236. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 237. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 238. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. NATO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 241. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 255. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 256. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 257. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 258. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 259. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 260. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 261. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 266. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 267. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 269. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 270. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 271. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 272. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 277. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 281. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 299. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 300. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 302. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 303. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 304. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 305. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 310. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 311. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 313. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 314. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 315. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 316. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 319. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 321. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 322. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, 2017-2032 (USD MILLION)
TABLE 324. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2017-2032 (USD MILLION)
TABLE 325. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 326. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 327. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 331. ITALY

Companies Mentioned

Abbott Laboratories
AELAB Guangzhou Co., Ltd.
Autobio Diagnostics Co., Ltd.
Beijing Succeeder Technology Inc.
Bio-Rad Laboratories, Inc.
Bio/Data Corporation
Cardinal Health
Danaher Corporation
Diagnostica Stago SAS
F. Hoffmann-La Roche Ltd.
Haemonetics Corporation
Helena Laboratories Corporation
HemoSonics LLC
HORIBA, Ltd.
IDEXX Laboratories, Inc.
Machaon Diagnostics, Inc.
Medsource Ozone Biomedicals Pvt. Ltd.
Mindray Medical International Limited
QuidelOrtho Corporation
Raj Biosis Private Limited
Randox Laboratories Ltd
Sekisui Medical Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
Sterile Safequip USA LLC
Sysmex Corporation
Thermo Fisher Scientific Inc.
Universal Biosensors Pty Ltd.
Werfen S.A.

Table Information

Report Attribute	Details
No. of Pages	196
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 7.28 Billion
Forecasted Market Value ( USD ) by 2032	$ 14.17 Billion
Compound Annual Growth Rate	11.6%
Regions Covered	Global
No. of Companies Mentioned	29

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3180EUR$3,545USD£2,719GBP €3534EUR$3,939USD£3,021GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4811EUR$5,363USD£4,113GBP €5346EUR$5,959USD£4,570GBP

Transformative Shifts in the Testing Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East & Africa

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

Key Country Insights Across Major Coagulation Testing Markets

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Coagulation Testing Market - Global Forecast 2026-2032

Thromboelastography Coagulation Analyzer Market - Global Forecast 2026-2032

Hemostasis/Coagulation Analyzer Market Outlook 2026-2034: Market Share and Growth Analysis

Coagulation Analyzer Market Outlook 2026-2031: Market Size, Strategic Acquisitions, and Technological Innovations in Hemostasis Testing

Hemostasis Diagnostic Devices and Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis